ArticleACS omega2025
Synthesis and Performance Evaluation of the Modified EVA Pour Point Depressants (PPDs) with Different Side Alkyl Chain Lengths.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Nano-SiOPolymers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graft modification of commercial EVA pour point depressants (PPDs) to prepare new PPDs with high performance is a research hotspot in the crude oil pipelining industry. However, the acting law and mechanism of the grafted EVA PPDs were still unclear. In this paper, based on a commercial EVA PPD (EVA-2), the modified EVA PPDs with different side alkyl chain lengths (EVA-4, EVA-10, and EVA-18) were successfully synthesized through a novel "alcoholysis-acyl substitution" reacting route. The effect of the side alkyl chain length (2-18) on the performance of the modified EVA PPDs for the model waxy oil without (MO-1)/with (MO-2) 500 ppm asphaltene was systemically studied. The influencing mechanism was also disclosed based on the microstructure of wax crystals, the asphaltene precipitation test, and the analysis of PPDs-paraffin wax-asphaltene interactions. For MO-1, the cocrystallization effect of the modified EVA PPDs and paraffin wax determines the performance of the PPDs. With the increase of side alkyl chain length, the cocrystallization effect first decreases and then increases, and the sequence is EVA-18 > EVA-2 > EVA-10 > EVA-4. The EVA-18 has the strongest cocrystallization effect and the best performance for MO-1, but the pour point reduction is only 4 °C. For MO-2, the performance of the modified EVA PPDs is governed by both the cocrystallization effect and the synergistic effect between the PPDs and asphaltene, and the synergistic effect significantly improves the performance of the PPDs. The synergistic effect is improved by increasing the side alkyl chain length. The EVA-18 PPD has the strongest cocrystallization effect and synergistic effect, which facilitate the formation of dense and the biggest wax aggregates. Therefore, EVA-18 has the largest pour point reduction of 14 °C for MO-2. These findings provide valuable insights into the role of alkyl side chain length in optimizing EVA-based PPDs, offering a promising strategy for mitigating flow assurance challenges in the pipeline transportation of waxy crude oils.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.